Inventor
GU TING-LEI
US21 patents
⚠️ This page may combine multiple inventors who share the name “GU TING-LEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL SIGNALING TECHNOLOGY INC
14 patentsUS7700339B2Apr 20, 2010
Gene defects and mutant ALK kinase in human solid tumors
CELL SIGNALING TECHNOLOGY INC22 citations92
US8377642B2Feb 19, 2013
Gene defects and mutant ALK kinase in human solid tumors
CELL SIGNALING TECHNOLOGY INC5 citations83
US7999080B2Aug 16, 2011
Reagents for the detection of protein phosphorylation in signaling pathways
CELL SIGNALING TECHNOLOGY INC6 citations69
US11505833B2Nov 22, 2022
Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations62
US10955416B2Mar 23, 2021
Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations62
US9988688B2Jun 5, 2018
Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC1 citations62
US9523130B2Dec 20, 2016
Methods of treating non-small cell lung carcinoma (NSCLC)
CELL SIGNALING TECHNOLOGY INC1 citations62
US9328349B2May 3, 2016
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
CELL SIGNALING TECHNOLOGY INC1 citations62
US10870892B2Dec 22, 2020
Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations51
US10526661B2Jan 7, 2020
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
CELL SIGNALING TECHNOLOGY INC0 citations51
US7888480B2Feb 15, 2011
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
CELL SIGNALING TECHNOLOGY INC0 citations48
US9539254B2Jan 10, 2017
Mutant ROS expression in human cancer
CELL SIGNALING TECHNOLOGY INC0 citations47
US7977462B2Jul 12, 2011
Tyrosine phosphorylation sites
CELL SIGNALING TECHNOLOGY INC1 citations47
US11099188B2Aug 24, 2021
ROS kinase in lung cancer
CELL SIGNALING TECHNOLOGY INC0 citations43
RIKOVA KLARISA
4 patentsUS8481279B2Jul 9, 2013
Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase
RIKOVA KLARISA6 citations83
US8288102B2Oct 16, 2012
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA5 citations72
US8168383B2May 1, 2012
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA5 citations72
US8486645B2Jul 16, 2013
Gene defects and mutant ALK kinase in human solid tumors
RIKOVA KLARISA2 citations61